Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Rhea-AI Summary

Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 2:00 p.m. ET in New York City.

The live event and replay will be available via the Events page of Lexicon's investor website.

News Market Reaction – LXRX

+1.84%

+1.84% Session close to close

In the May 28 session, LXRX gained 1.84%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Lexicon’s participation in a Jefferies Global Healthcare Conference fir...

Analysis

This announcement highlights Lexicon’s participation in a Jefferies Global Healthcare Conference fireside chat on June 4, 2026. It continues a pattern of active investor outreach, following recent earnings, financing, and clinical updates. Investors tracking the story may focus on any new commentary from management about liquidity, the Hercules loan facility, and progress in programs like SONATA‑HCM and pilavapadin as potential markers of future strategic direction.

Key Figures

Conference date: June 4, 2026 Event time: 2:00 p.m. ET

2 metrics

Conference date June 4, 2026 Jefferies Global Healthcare Conference fireside chat

Event time 2:00 p.m. ET Scheduled start time for conference fireside chat

Historical Context

5 past events · Latest: May 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 12	Investor conference	Positive	+4.3%	Announcement of fireside chat at H.C. Wainwright BioConnect conference.
May 07	Earnings & pipeline	Positive	+5.0%	Q1 2026 results with higher revenue and multiple clinical updates.
May 04	Debt financing	Positive	+3.1%	New Hercules loan facility providing up to $100M and refinancing prior debt.
Apr 30	Earnings date set	Positive	+3.9%	Announcement of date and call details for Q1 2026 earnings release.
Apr 17	Clinical data	Positive	+1.6%	AAN Phase 2b data supporting pilavapadin 10 mg for Phase 3 planning.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news, including conferences, earnings, and clinical updates, has consistently coincided with single-digit percentage gains, indicating a pattern of constructive reactions to company communications.

Recent Company History

Over the past months, Lexicon has reported stronger Q1 2026 financials, secured a new $100 million Hercules loan facility, and advanced multiple pipeline programs, including SONATA‑HCM and pilavapadin Phase 3 planning. It also announced several conference presentations, which historically saw modest positive price reactions. Today’s Jefferies conference fireside chat fits this pattern of regular investor engagement following financial and clinical progress updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals    
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.   

For Media Inquiries: 
Dave Belian 
Lexicon Pharmaceuticals, Inc. 
lexinvest@lexpharma.com  
  
For Investor Inquiries: 
Lisa DeFrancesco 
Lexicon Pharmaceuticals, Inc. 
lexinvest@lexpharma.com 

FAQ

When will Lexicon Pharmaceuticals (LXRX) present at the 2026 Jefferies Global Healthcare Conference?

Lexicon Pharmaceuticals will present a fireside chat on June 4, 2026, at 2:00 p.m. ET. According to Lexicon, the session is part of the 2026 Jefferies Global Healthcare Conference in New York City and features company management.

How can investors access Lexicon Pharmaceuticals’ 2026 Jefferies conference presentation for LXRX?

Investors can access the live event and replay through the Events page of Lexicon’s investor website. According to Lexicon, both the real-time webcast and an archived replay will be available for those unable to attend the 2026 Jefferies conference in person.

Where is Lexicon Pharmaceuticals’ fireside chat at the 2026 Jefferies Global Healthcare Conference being held?

Lexicon Pharmaceuticals’ fireside chat will be held in New York City as part of the 2026 Jefferies Global Healthcare Conference. According to Lexicon, the session is scheduled for June 4, 2026, at 2:00 p.m. ET and will also be webcast online.

What type of session will Lexicon Pharmaceuticals (LXRX) hold at the 2026 Jefferies Global Healthcare Conference?

Lexicon Pharmaceuticals plans to participate in a fireside chat with company management at the 2026 Jefferies Global Healthcare Conference. According to Lexicon, this discussion format will occur on June 4, 2026, at 2:00 p.m. ET and be available via webcast.

Where on Lexicon Pharmaceuticals’ website can LXRX investors find the Jefferies 2026 conference webcast?

LXRX investors can find the live webcast and replay on the Events page of Lexicon’s investor website. According to Lexicon, this page will host access links for the June 4, 2026, fireside chat from the 2026 Jefferies Global Healthcare Conference.